video thumbnail

Naloxone and Naltrexone (Pain Part 16)

Duration: 1:03:51

Write A New Comment

2 Comments

...

rpjseb@*.com

May 24 2024, 4:48 pm

Anyone actually figured out the CME bit? My record just shows 0!!!

...

tjm8922@*.com

May 22 2024, 3:04 pm

I see the answer to my question at 35 minutes

...

mobeen@*.com

May 22 2024, 5:55 am

Good to know!

Today we will discuss the first part of the Naloxone and Naltrexone topics. Naloxone and Naltrexone are synthetic modifications to oxymorphone. Which in turn is derived from morphine. Both naloxone and naltrexone are non-selective, competitive antagonists of the opioid receptors. Their affinity is variable for various types of receptors though. Naloxone is approved for over-the-counter opioid overdose prevention or reversal. It is available in the form of a nasal spray and intravenous preparation. Naltrexone on the other hand is prescription medicine for alcohol and opioid use disorders.

The following points will be discussed (objectives):
Opioid Overdose Management (FDA, DEA, and More)
What are Naloxone and Naltrexone?
Pharmacological properties.
Effects in the absence of opioid agonists.
Effects in the presence of opioid agonists.
Effects in opioid-dependent patients.
Absorption, distribution, metabolism, and elimination (ADME)

FDA Approves First Over-the-Counter Naloxone Nasal Spray | FDA
https://www.fda.gov/news-events/press-announcements/fda-approves-first-over-counter-naloxone-nasal-spray

Save Lives | DEA.gov
https://www.dea.gov/onepill/save-lives#:~:text=Naloxone%20is%20a%20medicine%20that,because%20of%20an%20opioid%20overdose.

Naloxone vs. Naltrexone: How These Opioid Blockers Differ - GoodRx
https://www.goodrx.com/conditions/opioid-use-disorder/naloxone-vs-naltrexone

Naloxone - Wikipedia
https://en.wikipedia.org/wiki/Naloxone

Naltrexone - Wikipedia
https://en.wikipedia.org/wiki/Naltrexone

Structures of morphine, oxymorphone buprenorphine, naloxone and... | Download Scientific Diagram
https://www.researchgate.net/figure/Structures-of-morphine-oxymorphone-buprenorphine-naloxone-and-naltrexone-Message_fig1_274901620

Reversal of opioid overdose syndrome in morphine-dependent rats using buprenorphine - ScienceDirect
https://www.sciencedirect.com/science/article/abs/pii/S0378427414015148#:~:text=The%20overshoot%20phenomenon%20may%20result,Olsen%2C%202011%2C%20Hassanian%2DMoghaddam

Basic opioid pharmacology: an update - PMC
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590096/

Fentanyl - StatPearls - NCBI Bookshelf
https://www.ncbi.nlm.nih.gov/books/NBK459275/

Frequently Asked Questions for NARCAN® Nasal Spray
https://narcan.com/frequently-asked-questions

Narcan (naloxone): Dosage, uses, side effects, and more
https://www.medicalnewstoday.com/articles/narcan#side-effects

* Understand opioid overdose management, including FDA and EDA guidelines.

* Define Naloxone and Naltrexone and their roles in opioid reversal.

* Describe the pharmacological properties of Naloxone and Naltrexone.

* Identify the effects of Naloxone and Naltrexone in the absence of opioid agonists.

* Recognize the effects of Naloxone and Naltrexone in the presence of opioid agonists.

* Explain the effects of Naloxone and Naltrexone in opioid-dependent patients.

* Discuss the absorption, distribution, metabolism, and elimination of Naloxone and Naltrexone

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.

Faculty

In addition to the presenter, following authors may have helped with the content writing, review, or approval:

  • Dr. Mobeen Syed

CME, CE, CEU and Other Credit Types:

ACCME Accreditation Statement
The DrBeen Corp is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The DrBeen Corp designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure Information

In accordance with the disclosure policies of DrBeen Corp and the ACCME (Accreditation Council for Continuing Medical Education), we are committed to upholding principles of balance, independence, objectivity, and scientific rigor in all of our Continuing Medical Education (CME) and Continuing Education (CE) activities. These policies include the careful management and mitigation of any relevant financial relationships with organizations that are not eligible.
All members of the Activity Planning Committee and presenters have disclosed their relevant financial relationships. The DrBeen Corp CE Committee has thoroughly reviewed these disclosures and determined that these relationships are not deemed inappropriate in the context of their respective presentations. Additionally, they are found to be consistent with the educational objectives and the integrity of the activity.

Faculty Disclosures
Dr. Mobeen Syed Author declares no conflict of interest.

Please login to access this content.

Don't have an account?

Start Your Free trial

No credit card information needed.

DEA Requirement for Opioid Use Disorder Management

Related Videos